Vasopressin Analogues and V1a Receptor Agonists in Septic Shock

Inflammation Research - Switzerland
doi 10.1007/s00011-011-0314-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Selective V1a Receptor Agonists in Experimental Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2007English

Low Dose Vasopressin in Septic Shock

Journal of the Intensive Care Society
Critical Care NursingCritical CareIntensive Care Medicine
2008English

Arginine Vasopressin V1a Receptor Antagonist Impairs Maternal Memory in Rats

Physiology and Behavior
PhilosophyBehavioral NeuroscienceExperimentalCognitive Psychology
2008English

Low Body Weight at Weaning in V1a Vasopressin Receptor Knockout Mice

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Vasopressin Versus Norepinephrine Infusion in Patients With Septic Shock

Survey of Anesthesiology
2009English

Azetidinones as Vasopressin V1a Antagonists

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2007English

Arginine Vasopressin in Septic Shock: Supplement or Substitute for Norepinephrine?

Critical Care
Critical CareIntensive Care Medicine
2009English

Physiology of Vasopressin Relevant to Management of Septic Shock

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2001English

Arginine–vasopressin and Corticosteroids in Septic Shock: Engaged but Not Yet Married!

Intensive Care Medicine
Critical CareIntensive Care Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy